Unaudited financial result for the quarter and half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pentokey Organy reported strong growth in Q2 FY26 with revenue from operations rising to ₹98.33 lakh from ₹22 lakh in Q2 FY25 (about 4.5x). For the half year, revenue jumped to ₹604.54 lakh from just ₹22 lakh in H1 FY25. Profit after tax for H1 FY26 stood at ₹62.71 lakh versus ₹15.13 lakh in the year-ago period, a more than 4x increase. Q2 PAT was ₹14.23 lakh vs ₹10.53 lakh. Basic EPS for H1 was ₹1.00 vs ₹0.24. The statutory auditor issued an unmodified (clean) limited review report. The company trades in the Pharma/Pesticides segment. An outstanding income tax demand of ₹171.58 lakh for AY 2015-16 is pending appeal. Trade receivables spiked sharply from ₹29.35 lakh to ₹675.98 lakh, and trade payables rose from ₹13.26 lakh to ₹453 lakh over the same period.
Strong top-line and bottom-line growth is positive, though it comes off a very small base, so the percentage gains look dramatic. The sharp jump in trade receivables warrants attention as it indicates large sums are owed to the company and collection delays could affect cash flow. Overall, a clean audit report and profitable growth are encouraging for shareholders.